Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8244890rdf:typepubmed:Citationlld:pubmed
pubmed-article:8244890lifeskim:mentionsumls-concept:C0028240lld:lifeskim
pubmed-article:8244890lifeskim:mentionsumls-concept:C0035608lld:lifeskim
pubmed-article:8244890lifeskim:mentionsumls-concept:C0870883lld:lifeskim
pubmed-article:8244890lifeskim:mentionsumls-concept:C1514468lld:lifeskim
pubmed-article:8244890lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:8244890lifeskim:mentionsumls-concept:C0450254lld:lifeskim
pubmed-article:8244890lifeskim:mentionsumls-concept:C0047394lld:lifeskim
pubmed-article:8244890pubmed:issue10lld:pubmed
pubmed-article:8244890pubmed:dateCreated1993-12-23lld:pubmed
pubmed-article:8244890pubmed:abstractTextRifampicin (1) was converted into four inactivated products by pathogenic Nocardia, RIP-1 and RIP-2 by N. brasiliensis and RIP-3 and RIP-4 by N. otitidiscaviarum. MS and NMR analysis showed the compounds to be 3-formyl-23-[O-(beta-D-glucopyranosyl)]rifamycin SV (2), 23-[O-(beta-D-glucopyranosyl)]rifampicin (3), 21-(O-phosphoryl)rifampicin (4) and 3-formyl-21-(O-phosphoryl)-rifamycin SV (5), respectively.lld:pubmed
pubmed-article:8244890pubmed:languageenglld:pubmed
pubmed-article:8244890pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8244890pubmed:citationSubsetIMlld:pubmed
pubmed-article:8244890pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8244890pubmed:statusMEDLINElld:pubmed
pubmed-article:8244890pubmed:monthOctlld:pubmed
pubmed-article:8244890pubmed:issn0021-8820lld:pubmed
pubmed-article:8244890pubmed:authorpubmed-author:YazawaKKlld:pubmed
pubmed-article:8244890pubmed:authorpubmed-author:MaedaAAlld:pubmed
pubmed-article:8244890pubmed:authorpubmed-author:MorisakiNNlld:pubmed
pubmed-article:8244890pubmed:authorpubmed-author:MikamiYYlld:pubmed
pubmed-article:8244890pubmed:authorpubmed-author:IwasakiSSlld:pubmed
pubmed-article:8244890pubmed:issnTypePrintlld:pubmed
pubmed-article:8244890pubmed:volume46lld:pubmed
pubmed-article:8244890pubmed:ownerNLMlld:pubmed
pubmed-article:8244890pubmed:authorsCompleteYlld:pubmed
pubmed-article:8244890pubmed:pagination1605-10lld:pubmed
pubmed-article:8244890pubmed:dateRevised2000-12-18lld:pubmed
pubmed-article:8244890pubmed:meshHeadingpubmed-meshheading:8244890-...lld:pubmed
pubmed-article:8244890pubmed:meshHeadingpubmed-meshheading:8244890-...lld:pubmed
pubmed-article:8244890pubmed:meshHeadingpubmed-meshheading:8244890-...lld:pubmed
pubmed-article:8244890pubmed:year1993lld:pubmed
pubmed-article:8244890pubmed:articleTitleInactivated products of rifampicin by pathogenic Nocardia spp.: structures of glycosylated and phosphorylated metabolites of rifampicin and 3-formylrifamycin SV.lld:pubmed
pubmed-article:8244890pubmed:affiliationInstitute of Molecular and Cellular Biosciences, University of Tokyo, Japan.lld:pubmed
pubmed-article:8244890pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8244890lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8244890lld:pubmed